scispace - formally typeset
Search or ask a question
Institution

University of Dundee

EducationDundee, United Kingdom
About: University of Dundee is a education organization based out in Dundee, United Kingdom. It is known for research contribution in the topics: Population & Protein kinase A. The organization has 19258 authors who have published 39640 publications receiving 1919433 citations. The organization is also known as: Universitas Dundensis & Dundee University.


Papers
More filters
Journal ArticleDOI
TL;DR: It is demonstrated that emollient therapy from birth represents a feasible, safe, and effective approach for atopic dermatitis prevention and would be a simple and low-cost intervention that could reduce the global burden of allergic diseases.
Abstract: Background Atopic dermatitis (atopic eczema) is a chronic inflammatory skin disease that has reached epidemic proportions in children worldwide and is increasing in prevalence. Because of the significant socioeconomic effect of atopic dermatitis and its effect on the quality of life of children and families, there have been decades of research focused on disease prevention, with limited success. Recent advances in cutaneous biology suggest skin barrier defects might be key initiators of atopic dermatitis and possibly allergic sensitization. Objective Our objective was to test whether skin barrier enhancement from birth represents a feasible strategy for reducing the incidence of atopic dermatitis in high-risk neonates. Methods We performed a randomized controlled trial in the United States and United Kingdom of 124 neonates at high risk for atopic dermatitis. Parents in the intervention arm were instructed to apply full-body emollient therapy at least once per day starting within 3 weeks of birth. Parents in the control arm were asked to use no emollients. The primary feasibility outcome was the percentage of families willing to be randomized. The primary clinical outcome was the cumulative incidence of atopic dermatitis at 6 months, as assessed by a trained investigator. Results Forty-two percent of eligible families agreed to be randomized into the trial. All participating families in the intervention arm found the intervention acceptable. A statistically significant protective effect was found with the use of daily emollient on the cumulative incidence of atopic dermatitis with a relative risk reduction of 50% (relative risk, 0.50; 95% CI, 0.28-0.9; P = .017). There were no emollient-related adverse events and no differences in adverse events between groups. Conclusion The results of this trial demonstrate that emollient therapy from birth represents a feasible, safe, and effective approach for atopic dermatitis prevention. If confirmed in larger trials, emollient therapy from birth would be a simple and low-cost intervention that could reduce the global burden of allergic diseases.

569 citations

Journal ArticleDOI
Jason Z. Liu1, Federica Tozzi2, Dawn M. Waterworth2, Sreekumar G. Pillai2, Pierandrea Muglia2, Lefkos T. Middleton3, Wade H. Berrettini4, Christopher W. Knouff2, Xin Yuan2, Gérard Waeber5, Peter Vollenweider5, Martin Preisig5, Nicholas J. Wareham6, Jing Hua Zhao6, Ruth J. F. Loos6, Ins Barroso7, Kay-Tee Khaw8, Scott M. Grundy, Philip J. Barter9, Robert W. Mahley10, Antero Kesäniemi11, Ruth McPherson12, John B. Vincent13, John Strauss13, James L. Kennedy13, Anne Farmer14, Peter McGuffin14, Richard O. Day15, Keith Matthews15, Per Bakke16, Amund Gulsvik16, Susanne Lucae17, Marcus Ising17, T. Brueckl17, S. Horstmann17, H.-Erich Wichmann18, Rajesh Rawal, Norbert Dahmen19, Claudia Lamina20, Ozren Polasek21, Lina Zgaga22, Jennifer E. Huffman22, Susan Campbell22, Jaspal S. Kooner3, John C. Chambers3, Mary Susan Burnett23, Joseph M. Devaney23, Augusto D. Pichard23, Kenneth M. Kent23, Lowell F. Satler23, Joseph M. Lindsay23, Ron Waksman23, Stephen E. Epstein23, James F. Wilson22, Sarah H. Wild22, Harry Campbell22, Veronique Vitart22, Muredach P. Reilly4, Mingyao Li4, Liming Qu4, Robert L. Wilensky4, William H. Matthai4, Hakon Hakonarson4, Daniel J. Rader4, Andre Franke24, Michael Wittig24, Arne Schäfer24, Manuela Uda25, Antonio Terracciano26, Xiangjun Xiao27, Fabio Busonero25, Paul Scheet27, David Schlessinger26, David St Clair28, Dan Rujescu18, Gonçalo R. Abecasis29, Hans J. Grabe30, Alexander Teumer30, Henry Völzke30, Astrid Petersmann30, Ulrich John30, Igor Rudan31, Igor Rudan22, Caroline Hayward22, Alan F. Wright22, Ivana Kolcic21, Benjamin J. Wright32, John R. Thompson32, Anthony J. Balmforth33, Alistair S. Hall33, Nilesh J. Samani32, Carl A. Anderson7, Tariq Ahmad, Christopher G. Mathew34, Miles Parkes, Jack Satsangi22, Mark J. Caulfield35, Patricia B. Munroe35, Martin Farrall1, Anna F. Dominiczak36, Jane Worthington, Wendy Thomson, Steve Eyre, Anne Barton, Vincent Mooser2, Clyde Francks2, Clyde Francks1, Jonathan Marchini1 
TL;DR: The Oxford-GlaxoSmithKline study (Ox-GSK) as discussed by the authors performed a genome-wide meta-analysis of SNP association with smoking-related behavioral traits and found an effect on smoking quantity at a locus on 15q25 (P = 9.45 x 10(-19) that includes CHRNA5, CHRNA3 and CHRNB4.
Abstract: Smoking is a leading global cause of disease and mortality. We established the Oxford-GlaxoSmithKline study (Ox-GSK) to perform a genome-wide meta-analysis of SNP association with smoking-related behavioral traits. Our final data set included 41,150 individuals drawn from 20 disease, population and control cohorts. Our analysis confirmed an effect on smoking quantity at a locus on 15q25 (P = 9.45 x 10(-19)) that includes CHRNA5, CHRNA3 and CHRNB4, three genes encoding neuronal nicotinic acetylcholine receptor subunits. We used data from the 1000 Genomes project to investigate the region using imputation, which allowed for analysis of virtually all common SNPs in the region and offered a fivefold increase in marker density over HapMap2 (ref. 2) as an imputation reference panel. Our fine-mapping approach identified a SNP showing the highest significance, rs55853698, located within the promoter region of CHRNA5. Conditional analysis also identified a secondary locus (rs6495308) in CHRNA3.

568 citations

Journal ArticleDOI
TL;DR: The aim of this short article is to summarize the progress being made by the nomenclature committee of IUPHAR in formulating recommendations that attempt to address issues related to ligand-gated ion channels.

565 citations

Journal ArticleDOI
28 Jan 1999-Nature
TL;DR: Surprisingly, the M2 region of the 5-HT3B subunit lacks any of the structural features that are known to promote the conductance of related receptors, and will be a valuable resource for defining the molecular mechanisms of ion-channel function.
Abstract: The neurotransmitter serotonin (5-hydroxytryptamine or 5-HT) mediates rapid excitatory responses through ligand-gated channels (5-HT3 receptors). Recombinant expression of the only identified receptor subunit (5-HT3A) yields functional 5-HT3 receptors1. However, the conductance of these homomeric receptors (sub-picosiemens) is too small to be resolved directly, and contrasts with a robust channel conductance displayed by neuronal 5-HT3 receptors (9–17 pS)2,3,4,5,6,7. Neuronal 5-HT3 receptors also display a permeability to calcium ions and a current–voltage relationship that differ from those of homomeric receptors3,4,5,8. Here we describe a new class of 5-HT3-receptor subunit (5-HT3B). Transcripts of this subunit are co-expressed with the 5-HT3A subunit in the amygdala, caudate and hippocampus. Heteromeric assemblies of 5-HT3A and 5-HT3B subunits display a large single-channel conductance (16 pS), low permeability to calcium ions, and a current–voltage relationship which resembles that of characterized neuronal 5-HT3 channels. The heteromeric receptors also display distinctive pharmacological properties. Surprisingly, the M2 region of the 5-HT3B subunit lacks any of the structural features that are known to promote the conductance of related receptors. In addition to providing a new target for therapeutic agents, the 5-HT3B subunit will be a valuable resource for defining the molecular mechanisms of ion-channel function.

565 citations

Journal ArticleDOI
TL;DR: The Normalization Process Model is broken down to show that it is consistent and adequate in generating accurate description, systematic explanation, and the production of rational knowledge claims about the workability and integration of complex interventions.
Abstract: The Normalization Process Model is a theoretical model that assists in explaining the processes by which complex interventions become routinely embedded in health care practice. It offers a framework for process evaluation and also for comparative studies of complex interventions. It focuses on the factors that promote or inhibit the routine embedding of complex interventions in health care practice. A formal theory structure is used to define the model, and its internal causal relations and mechanisms. The model is broken down to show that it is consistent and adequate in generating accurate description, systematic explanation, and the production of rational knowledge claims about the workability and integration of complex interventions. The model explains the normalization of complex interventions by reference to four factors demonstrated to promote or inhibit the operationalization and embedding of complex interventions (interactional workability, relational integration, skill-set workability, and contextual integration). The model is consistent and adequate. Repeated calls for theoretically sound process evaluations in randomized controlled trials of complex interventions, and policy-makers who call for a proper understanding of implementation processes, emphasize the value of conceptual tools like the Normalization Process Model.

563 citations


Authors

Showing all 19404 results

NameH-indexPapersCitations
Matthias Mann221887230213
Mark I. McCarthy2001028187898
Stefan Schreiber1781233138528
Kenneth C. Anderson1781138126072
Masayuki Yamamoto1711576123028
Salvador Moncada164495138030
Jorge E. Cortes1632784124154
Andrew P. McMahon16241590650
Philip Cohen154555110856
Dirk Inzé14964774468
Andrew T. Hattersley146768106949
Antonio Lanzavecchia145408100065
Kim Nasmyth14229459231
David Price138168793535
Dario R. Alessi13635474753
Network Information
Related Institutions (5)
University of Edinburgh
151.6K papers, 6.6M citations

95% related

University College London
210.6K papers, 9.8M citations

95% related

University of Manchester
168K papers, 6.4M citations

94% related

Imperial College London
209.1K papers, 9.3M citations

94% related

University of Cambridge
282.2K papers, 14.4M citations

93% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202361
2022205
20211,653
20201,520
20191,473
20181,524